These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 4083271)
21. Evaluation of intramuscular levonantradol and placebo in acute postoperative pain. Jain AK; Ryan JR; McMahon FG; Smith G J Clin Pharmacol; 1981; 21(S1):320S-326S. PubMed ID: 7028791 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and Safety of Oral NEPA (Netupitant/Palonosetron), the First Fixed-Combination Antiemetic, in Patients With Gynecological Cancers Receiving Platinum-Based Chemotherapy. Bošnjak SM; Stamatovic L; Borroni ME; Rizzi G; Jordan K Int J Gynecol Cancer; 2018 Jul; 28(6):1153-1161. PubMed ID: 29794499 [TBL] [Abstract][Full Text] [Related]
23. Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy. Stuart-Harris RC; Mooney CA; Smith IE Clin Oncol; 1983 Jun; 9(2):143-6. PubMed ID: 6309451 [TBL] [Abstract][Full Text] [Related]
24. Dose-ranging evaluation of the serotonin antagonist GR-C507/75 (GR38032F) when used as an antiemetic in patients receiving anticancer chemotherapy. Kris MG; Gralla RJ; Clark RA; Tyson LB J Clin Oncol; 1988 Apr; 6(4):659-62. PubMed ID: 2965755 [TBL] [Abstract][Full Text] [Related]
25. Comparison of oral versus intravenous ramosetron in prevention of acute cisplatin-induced emesis: a randomized controlled trial. Tantipalakorn C; Srisomboon J; Thienthong H; Pantusart A; Suprasert P; Saereesongkhun C; Eamtang S; Sutthichat A; Pautad N J Med Assoc Thai; 2004 Feb; 87(2):119-25. PubMed ID: 15061293 [TBL] [Abstract][Full Text] [Related]
26. [Levonantradol as an antiemetic in cancer chemotherapy]. Mella O; Følling Elgjo R; Isaksen H; Klepp O Tidsskr Nor Laegeforen; 1984 Nov; 104(33):2320-2. PubMed ID: 6523465 [No Abstract] [Full Text] [Related]
27. Comparison of ondansetron with metoclopramide in prevention of acute emesis associated with low dose & high dose cisplatin chemotherapy. Bhatia A; Tripathi KD; Sharma M Indian J Med Res; 2003 Jul; 118():33-41. PubMed ID: 14748464 [TBL] [Abstract][Full Text] [Related]
28. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer]. Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069 [TBL] [Abstract][Full Text] [Related]
29. Ondansetron (GR 38032F): a novel antiemetic effective in patients receiving a multiple-day regimen of cisplatin chemotherapy. Hainsworth JD; Omura GA; Khojasteh A; Bryson JC; Finn AL Am J Clin Oncol; 1991 Aug; 14(4):336-40. PubMed ID: 1830716 [TBL] [Abstract][Full Text] [Related]
30. High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study. Gez E; Warner-Efraty E; Ben-Yosef R; Ben-Baruch N; Yitzhaki N; Uziely B; Brufman G; Biran S Oncology; 1987; 44(4):237-9. PubMed ID: 3614813 [TBL] [Abstract][Full Text] [Related]
31. Levonantradol effectiveness in cancer patients resistant to conventional anti-emetics. Kenny JB; Wilkinson PM Clin Oncol; 1982 Dec; 8(4):335-9. PubMed ID: 7168926 [No Abstract] [Full Text] [Related]
32. Modified oral ondansetron regimen for cyclophosphamide-induced emesis in lupus nephritis. Yarboro CH; Wesley R; Amantea MA; Klippel JH; Pucino F Ann Pharmacother; 1996; 30(7-8):752-5. PubMed ID: 8826554 [TBL] [Abstract][Full Text] [Related]
33. Trial of droperidol as an antiemetic in cisplatin chemotherapy. Kelley SL; Braun TJ; Meyer TJ; Rempel P; Pearlman NW Cancer Treat Rep; 1986 Apr; 70(4):469-72. PubMed ID: 3698040 [TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind comparison of single-dose and divided multiple-dose dolasetron for cisplatin-induced emesis. Harman GS; Omura GA; Ryan K; Hainsworth JD; Cramer MB; Hahne WF Cancer Chemother Pharmacol; 1996; 38(4):323-8. PubMed ID: 8674154 [TBL] [Abstract][Full Text] [Related]
36. Chemotherapy-induced emesis: management of early and delayed emesis in milder emetogenic regimens. Barrenetxea G; Schneider J; Centeno MM; Romero H; de la Rica M; Rodríguez-Escudero FJ Cancer Chemother Pharmacol; 1996; 38(5):471-5. PubMed ID: 8765442 [TBL] [Abstract][Full Text] [Related]
37. Ondansetron + dexamethasone vs metoclopramide + dexamethasone + diphenhydramine in prevention of cisplatin-induced emesis. Italian Group For Antiemetic Research. Lancet; 1992 Jul; 340(8811):96-9. PubMed ID: 1352024 [TBL] [Abstract][Full Text] [Related]
38. Phase II trial of ramosetron plus dexamethasone in the prevention of cisplatin-induced nausea and vomiting. Voravud N; Sriuranpong V J Med Assoc Thai; 2005 Dec; 88(12):1790-6. PubMed ID: 16518975 [TBL] [Abstract][Full Text] [Related]